By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Celldex Therapeutics, Inc. 

222 Cameron Drive
Suite 400
Phillipsburg  New Jersey  08865  U.S.A.
Phone: 908-454-7120 Fax: 908-454-1911


SEARCH JOBS


Industry
Biotechnology






Company News
Celldex Therapeutics, Inc. (CLDX) Release: Interim Update From Randomized Phase 2 ReACT Study Of Rindopepimut In Recurrent Bevacizumab-Naive Glioblastoma Demonstrates Statistically Significant Survival Benefit 11/17/2014 10:30:09 AM
Oncothyreon Inc. (ONTY) And Celldex Therapeutics, Inc. (CLDX) Announce Initiation Of Combination Immunotherapy Clinical Trial Of ONT-10 And Varlilumab 11/11/2014 7:33:42 AM
Celldex Therapeutics, Inc. (CLDX) Presents Varlilumab Proof Of Concept Data At SITC Annual Meeting 2014 11/7/2014 12:17:34 PM
Celldex Therapeutics, Inc. (CLDX) Reports Third Quarter 2014 Results 11/5/2014 7:43:06 AM
Celldex Therapeutics, Inc. (CLDX) Announces Upcoming Presentations of Rindopepimut Data at 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) 11/3/2014 10:13:46 AM
Celldex Therapeutics, Inc. (CLDX) Announces Publication Of Glembatumumab Vedotin Phase 1/2 Studies In The Journal Of Clinical Oncology 9/30/2014 9:14:10 AM
Celldex Therapeutics, Inc. (CLDX) Initiates Pilot Study Of CDX-301 In Allogeneic Hematopoietic Stem Cell Transplantation 9/25/2014 8:25:28 AM
Celldex Therapeutics, Inc. (CLDX) Announces Upcoming Presentation At The Morgan Stanley (MST) Healthcare Conference 9/4/2014 7:55:53 AM
Celldex Therapeutics, Inc. (CLDX) Reports Second Quarter 2014 Results 8/6/2014 4:29:53 PM
Celldex Therapeutics, Inc. (CLDX) Announces Senior Leadership Promotions 7/30/2014 10:43:37 AM
12345678910...
//-->